1-2 of 2
Ly Dsouza
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A First-in-Human Phase 1, Multicenter, Open-Label Study of CB-010, a Next-Generation CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy with a PD-1 Knockout, in Patients with Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER Study)

Susan O'Brien, Loretta J. Nastoupil, James Essell, Ly Dsouza, Doug Hart, Emiri Matsuda, Tarah Satterfield, Tonia Nesheiwat, Ashley Hammad, Franco Davi, Shally Chung, S. Asim Shamsi, Mara Bryan, Justin Skoble, Elizabeth Garner, Steven Kanner, Syed Rizvi, Houston Holmes
Journal: Blood
Blood (2022) 140 (Supplement 1): 9457–9458.
https://doi.org/10.1182/blood-2022-168128
Published: 2022
Journal Articles

High Complete Response Rates with Pembrolizumab in Combination with Rituximab in Patients with Relapsed Follicular Lymphoma: Results of an Open-Label, Phase II Study

Loretta Nastoupil, MD, Jason R. Westin, MD, Nathan H. Fowler, MD, Michelle A. Fanale, MD, Felipe Samaniego, MD, Yasuhiro Oki, MD, Ly Dsouza, PA-C, Chizobam Obi, RN, JingJing Cao, Xiaoyun Cheng, Man Chun John MA, PhD, Wang Zhiqiang, Lei Feng, MS, Shouhao Zhou, R. Eric Davis, MD, Sattva S. Neelapu, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 414.
https://doi.org/10.1182/blood.V130.Suppl_1.414.414
Published: 2017